On September 13, 2021, ThinkGenetic was officially named a finalist for The Horizon Prize, a global innovation challenge seeking solutions to speed diagnosis and care for people impacted by rare disease.
The Horizon Prize, powered by MIT Solve, seeks technology-based solutions that use data to help rare disease patients get the right care faster and more accurately. To that end, this Challenge seeks solutions that:
- Leverage big data and analytics to improve the detection and diagnosis of rare diseases
- Address the unjust and disproportionate burden of rare diseases faced by disinvested communities and historically underrepresented identity groups
- Promote community and connection among rare disease patients and their advocates
- Unlock collaboration among patients, scientists, and health care providers to improve patient outcomes
The finalist presentations will take place September 20, 2021 in New York City, with an official announcement of the winner at the event. Up to $150,000 in prize funding is available for up to two solution teams selected for The Horizon Prize.
To learn more about MIT Solve and follow the competition, visit: https://solve.mit.edu/challenges/horizonprize/solutions/46248.